Remote Data Capture of Elevated Temperature Data for Early Detection of Febrile Neutropenia in Patients With Hematologic Malignancies
The BioSticker device, developed by BioIntelliSense, Inc. and utilized in this clinical trial, represents a significant advancement in remote patient monitoring technology, particularly for patients undergoing treatment for hematologic malignancies. The potential for real-time alerts for febrile neutropenia (FN) could enhance patient safety and reduce hospitalizations, thereby improving overall treatment outcomes. The market for remote monitoring devices is expanding rapidly, driven by increasing demand for telehealth solutions and chronic disease management. The successful implementation of this technology could position BioIntelliSense favorably against competitors in the digital health space, particularly in oncology. Stakeholders should consider the implications of this technology on patient management protocols and the potential for integration into existing healthcare systems.
Indication: Hematologic Malignancy
Modality: medical device
Target: Remote monitoring of elevated temperature data for early detection of febrile neutropenia in patients with hematologic malignancies.
Sponsor: University of Colorado, Denver
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jun 12, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Remote monitoring of elevated temperature data for early detection of febrile neutropenia in patients with hematologic malignancies.
View original source fields
Condition raw: Hematologic Malignancy
Condition normalized: Hematologic Malignancy
Modality raw: medical device
Modality normalized: medical device
Target raw: Remote monitoring of elevated temperature data for early detection of febrile neutropenia in patients with hematologic malignancies.
Target normalized: Remote monitoring of elevated temperature data for early detection of febrile neutropenia in patients with hematologic malignancies.